Evaluation of some Herbal Agents in the treatment of Diabetes in Comparison to Insulin

Author:

F. H. Al-Musawi Jawad1

Affiliation:

1. Thi-Qar Medical College of Thi-Qar University, Department of Pharmacology and Therapeutic, Iraq.

Abstract

We conducted an experimental investigation in which hyperglycemia was created in rats using Alloxan; we then employed an herbal drug that could reverse the hypoglycemic effects of insulin, which is to say, we used Alloxan to induce hyperglycemia in the rats. Research conducted on 24 Black rats over 28 days (split into four groups of six rats each on days 1, 7, 14, and 28) shows that ALLOXAN can induce hyperglycemia with statistical significance (P0.0001). HERBAL DRUGS (Momordica Charantia L) have effectively reduced hyperglycemia brought on by Alloxan, with statistically significant results (P0.0001) but not as strong as those produced by insulin. Momordica Charantia L for its insulin-like effects on blood sugar levels in the context of hyperglycemia produced by Alloxan. Through the use of "Black rats," we were able to successfully visualize a model for inducing hyperglycemia via intraperitoneal injection of ALLOXAN. The effectiveness of Momordica charantia L in bringing down hyperglycemia was then compared to that of insulin. Comparing Momordica charantia L to insulin for the treatment of type 1 diabetes in rats, the following results were found: - On days 7, 14, 21, and 28, with a total of 6 animals (Black rats) in each group, the mean S.D. of the hypoglycemic effect of Momordica charantia L was (148.42 +/-3.65), (127.66 +/- 2.520), (95.78 +/-1.18), and (86.54 +/3.55). To put it another way, the herbal remedy effectively lowers blood sugar levels in those who suffer from hyperglycemia. The present findings highlight that Momordica charantia L effectively treats type 1 diabetes mellitus in rats and has the same effect on blood glucose levels as pharmaceutical insulin. Keywords: Alloxan, Hypoglycemia, Insulin, Momordica charantia L, Hyperglycemia.

Publisher

Clinical Biotec

Subject

Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3